Securian Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
QF
FCM
Securian Asset Management's ROIV Position: Q2 2026 in Review
Securian Asset Management increased its Roivant Sciences (ROIV) stake by 0.12% in Q2 2026, buying an estimated $1.21K and bringing the position to 33,276 shares worth $1.15M. The position accounts for 0.04% of the portfolio, ranked #310.
Securian Asset Management first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- Securian Asset Management held 33,276 shares of Roivant Sciences worth $1.15M as of Q2 2026.
- Securian Asset Management bought 41 Roivant Sciences shares in Q2 2026, an estimated $1.21K.
- Roivant Sciences made up 0.04% of Securian Asset Management's portfolio in Q2 2026, its #310 holding.
- Securian Asset Management first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
- 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.